Background: Human parathyroid hormone (hPTH) is a promising anabolic agent. However, since hPTH (1-34) is available only via injection, and has a critical side effect of causing bone tumors during life-long administration in the rat, it would be practical to use PTH for the shortest possible duration to obtain the maximal effect. In addition, acquired bone mass due to hPTH tend to decrease after drug cessation. To determine the effectiveness of the osteoporosis-reversing concept of lose, restore, and maintain (LRM), recombinant human PTH(1-84) ] and the respective anti-resorptive agents were sequentially studied.
2. 미세골구조 (microarchitecture) 0.25 ± 0.03
Footnote: Data are shown as the mean ± SD. The cortical bones of the femora diaphysis were examined using the three-point bending test to measure the ultimate force (Fu), ultimate stress (οu), stiffness (S), Young's modulus (E) and ultimate strain (εu). I denotes the moment of inertia. o: P < 0.0001 vs. OVX, s: P < 0.05 vs SHAM, o': P < 0.05 vs. OVX 
